Tweet Archive for April 2022
RT @ducrest: #Acne #AcneAwareness
Isotretinoin does not contribute to increased neuropsychiatric risk in the overall acne population, but r…
RT @DrJohnBarbieri: @ducrest @BrJDermatol @WileyHealth @SandraLeeMD
Thoughtfully designed matched cohort study in @BrJDermatol finding that #isotretinoin use in #acne is associated with reduced risk of neuropsychiatric outcomes for those with moderate-to-severe acne.@seenafazel #dermtwitterhttps://t.co/H6D813XHxq
— John Barbieri, MD, MBA (@DrJohnBarbieri) April 13, 2022
#Acne #AcneAwareness
Isotretinoin does not contribute to increased neuropsychiatric risk in the overall acne popula…
https://twitter.com/i/web/status/1519736305428619266
Molecular analysis of inflammatory diseases onlinelibrary.wiley.com/doi/abs/10.111…
via @ExpDermatol
#dermatology #dermatologia #dermtwitter
#PsoriasisAwareness #PsoriaticDisease
Would previous use of TNF inhibitors affect the therapeutic effect of anti IL…
https://twitter.com/i/web/status/1519731450798559237
RT @AdeAdamson: “I do not believe we should be comfortable with continuing to send the message to patients that melanoma screening saves li…
RT @PennLDI: NEW: LDI Fellow @juleslipoff reviews the history, risks, and benefits of direct-to-consumer (DTC) #telemedicine, and looks to…
Severity of psoriasis: time to disentangle severity from symptom control via @BrJDermatol @WileyHealth…
https://twitter.com/i/web/status/1519373493745471491
#Korean experience – Changes in beauty mobile shopping
onlinelibrary.wiley.com/doi/10.1111/jo…
a @WileyHealth free access article